2,4,6-Triphenylpyridine, 98%, 5g

3-(2-((tert-Butoxycarbonyl)amino)ethoxy)benzoic acid, 95%, 500mg

2,6-dimethylaniline, >=98%, for synthesis, 1L, glass packaging

Pentamethylbenzene, 98.0%, 5g

(R)-Methyl 2-(benzylamino)-3-hydroxypropanoate, 95.0%, 5g

6-amino-1,3-dimethyl-5-nitrosopyrimidine-2,4(1H,3H)-dione, 25g

2-tert-Butyloxycarbonylaminomethyl-5-methyl-[1,3,4]oxadiazole, 95.0%, 5g

4-Bromo-cyclohexylamine hydrochloride, 95.0%, 1g

3-(5-ethyl-4H-1,2,4-triazol-3-yl)aniline, 95.0%, 250mg

Methyl 4-bromothieno[2,3-c]pyridine-2-carboxylate, 95.0%, 25g

3-(Bromomethyl)-5-fluorobenzonitrile, 98%, 1g

Ethyl 6,8-dichlorooctanoate, 95.0%, 500g

6-(4-AMINO-4-METHYLPIPERIDIN-1-YL)-3-(2,3-DICHLOROPHENYL)PYRAZIN-2-AMINE, 95.0%, 10mg